Market Research Blog

According to the latest research by Future Market Insights, interlaminar device market is set to witness a growth 5.4% during the year 2021-2031. Interlaminar device normally relates to the disease defined by the compression of nerve roots and shrinking of the spinal canal due to many pathologic causes, further leads to symptoms such as pain with a tingling feeling, numbness, and weakness. Spinal stenosis can include the cervical, lumbar, or thoracic (rarely) spine.

What is Driving Demand for Interlaminar Device?

The growth for interlaminar device is driven by various factors including advancements in spine surgery technologies, increasing incidence of spinal disorders, the launch of advanced bone grafting products, and the increasing adoption of minimally invasive spine surgeries.

Furthermore, key players across the globe focus on advancements in terms of technology to improve the interlaminar device efficacy and expanding their application in the market and assist with inventive growth opportunities. Furthermore, introducing unique product in the market allows businesses to acquire a competitive edge and increase product adoption.

Get Customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/14214

Which factors are likely to Augment Growth of Interlaminar Device Market?

The growth of interlaminar device is likely to be boosted by technological factors which benefits include a shorter hospital stay and recovery time, faster and longer-lasting relief from discomfort, better treatment adaptability, and adjacent layers are naturally moving.

For instance, in May 2018 Paradigm Spine disposable instrument kit coflex® Interlaminar stabilization gets FDA pre-market approval. Coflex® interlaminar stabilization is an exclusive posterior lumbar motion preservation solution which offers long-term outcomes for patients with moderate to severe spinal stenosis.

U.S. and Canada Interlaminar Device Market Outlook

The region of North America accounts for highest market share in the current scenario for interlaminar device. The increasing adoption and penetration of interlaminar device into US and Canada market is mainly due to  a rise in the number patients with spinal cord injury, better healthcare facilities, and organizations like the North American Spine Foundation all working to raise awareness and educate healthcare providers and public about different medical condition.

As per data published by National Spinal Cord Injury Statistical Center, in 2017, approximately 285,000 people in the U.S. are estimated to be suffering from spinal cord injuries.

Europe Demand Outlook for Interlaminar Device

The European region is set to witness a dominant demand for interlaminar device due to the improving healthcare infrastructure, rising awareness, improving reimbursement scenario, and the growing insurance coverage are the major key factor to boost the growth in European region.

Some other factors are rising treatment rates for degenerative spine diseases, rising geriatric population, medical technological advances, and a growth in the demand for minimally invasive treatments are all contributing factors to this trend in Europe.

Who are the Key Manufacturers and Suppliers of Interlaminar Device?

The key companies operating in manufacturing and supply of interlaminar device market include

• NuVasive
• Life Spine
• Lanx acquired by BioMet
• X-Spine
• Pioneer Surgical
• Alphatec
• Paradigm Spine
• Spine Frontier
• Amedica Corp.
• Bioventus
• Camber Spine Technologies
• DePuy Synthes
• Implanet
• Mazor Robotics
• Meditech Spine.

The key players adopt growth strategies for product portfolio expansion by designing novel interlaminar device. The companies also have extensive distribution systems for effective sales revenue generation.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For critical insights, request for PDF Brochure@

https://www.futuremarketinsights.com/reports/brochure/rep-gb-14214

Interlaminar Device Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

Key Segments

By Product Type:

• Interspinous Distraction Devices
• Coflex Device

By Technology:

• Fusion and Fixation Technology
• Vertebral Compression Fracture Treatment
• Motion Preservation Technologies

By Type of Surgery:

• Open Surgery
• Minimally Invasive surgery

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

 

According to the latest research by FMI, EMG biosensors market is set to experience steady growth during the year 2021-2031. With increasing importance of continuous health monitoring, the market according to research conducted by Fact.MR will see a steady growth over the forecast period of 2021-2031 with a CAGR of around 6.7%.

What is Driving the Demand for EMG Biosensors market?

Skeletal muscles in the human body carry out their function of contracting and relaxing with help of electrical signals directed by the brain. EMG or Electromyograph is type of device that measure this electrical activity.

Any variation in these patterns can point to a disturbance in the standard muscular function. This activity can be widely measured and analysed in two forms; pattern recognition and signal intensity.

Abnormal pattern in the former can indicate towards a potential muscular complication. The later, however, helps in determining the strength of the electrical signals reaching the muscles from the brain. Low signal points towards a probable electrical conduction issue in these skeletal muscles and vice versa.

These biosensors apart from EMG have diversity in their application, ranging from monitoring of heart rate, neural study and dermal study. This is an important factor in driving this market towards an optimistic future.

Growing awareness of continuous health monitoring is another crucial factor in driving this market ahead. This has recently gained more popularity among the athletes. Many athletes use this EMG biosensors to closely monitor their health, and notifies them in case of health concerns. This early detection will help athletes perform better and help them stay ahead of their game.

With technological advancements, biosensor technology is integrated in smart bands, smart watches, and smart rings which help monitor health parameters on the move 24/7. Although this may open up new avenues, but data accuracy is one of the concern which is likely to have negative impact on the market growth.

Development of Novel EMG Biosensors to Create lucrative Growth Opportunities.

According to article published by American Institute of Physics in their APL Materials journal (24 August 2021) use of nanocomposites made from materials like gold and silver which can be used in EMG biosensors.

Textile-based and affordable silver (Ag) micro-flakes were fabricated and then gold (Au) nano-particles were electrochemically deposited on the Ag. This process helped the researchers in increasing the bioavailability, biocompatibility and surface area of the particles.

It was inferred that the signals received during the myography were detected with more ease and accuracy than the normal biosensors. Bicep and finger movements were recorded to show the most sensitivity among other movements. Discoveries like these venturing into novel avenues to improve existing infrastructure will reinforce the growth of EMG biosensors market.

Get Customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/14216

U.S and Canada EMG Biosensors Market

Advanced health edifice combined with standardized policies will help the U.S market towards a growth. The presence of major players will certainly prove beneficial for the market as with increasing research in finding out various applications of these bioreactors will certainly impact the market positively.

Apart from this, Washington Post reported that USA has the highest number of athletes in the Olympics. As continuous health monitoring plays an important role in athlete’s career, the presence of large number of athletes will positively drive the sales of EMG biosensors in this region.

Europe EMG Biosensors Market

Europe is the second most lucrative market owing to the European Union’s efforts to setup a novel technique in health monitoring. This technique is known as the Surface ElectroMyoGraphy for the Non-Invasive Assessment of muscles or SENIAM. EU’s Biomedical Health and Research P7rogramme has setup this technique. This technique consists of a set of simulation models for education and testing, a set of test signals, eight books, publications and a European network for SEMG: the SENIAM club.

Some of the Key player operating in Europe include; TMSi (Netherlands), Bitbrain Technologies (Spain), and LUX Wireless Biosignals S.A (Portugal).

Who are the key Manufacturing Supplying Companies in EMG Biosensors Market?

Key manufacturers and suppliers in the market are

• Biometrics Ltd. (US)
• Delsys Incorporated (US)
• Butler Technologies (Ireland)
• iMotions (Denmark)
• EB Neuro S.p.A. (Italy)
• Compumedics NeuroScan (United States)
• OpenBCI (US)
• Ceribell Inc. (United States) and others.

For critical insights, request for PDF Brochure@

https://www.futuremarketinsights.com/reports/brochure/rep-gb-14216

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

EMG Biosensors Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

Key Segment

By Type:

• Surface Biosensors
• Intramuscular Biosensors

By Technique:

• Signal Intensity Registration
• Pattern Recognition

By End User:

• Hospitals and Clinics
• Ambulatory Health Clinics
• Academic and Research Centres

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, quadriplegia treatment market is expected to grow at a CAGR of 4.1% during the forecast period. The demand for quadriplegia treatment will progressively rise, which will provide manufacturers with numerous favorable development opportunities in the near future.

What are the key Drivers of Quadriplegia Treatment Market?

Quadriplegia is caused by spinal cord injury which is caused due to trauma at the base of the neck or skull. Some of the common causes of quadriplegia, otherwise known as tetraplegia are paralysis after any accident, tumors of the spinal cord or other spinal cord diseases. The injury to the spinal cord may cause partial or total limb paralysis.

According to 2020 data sheet of Spinal Cord Injury Statistics, it was estimated that approximately 17,810 new cases of spinal cord injuries occur every year in the U.S. Some of the reasons for quadriplegia include stroke, vehicular accidents, falls, violence, sports, medical or surgical causes and others.

According to WHO statistics, published in June 2021, 20-50 million people suffer from road traffic accidents every year which lead to non-fatal injuries yet permanent disabilities to them. With the increasing rate of road traffic accidents, the demand for quadriplegia treatment is set to show a positive growth over the forecast period.

Recent technological advancements and various R&D activities in the field of quadriplegia treatment are one of the leading causes which will boost the demand for this market in forthcoming years. There is an increased level of awareness amongst the patients suffering from spinal cord injuries about various treatment options available to improve their quality of life. This is another factor which will propel the demand for various treatments for quadriplegia during the forecast market.

Get Customization on Pre-Booking:

https://www.futuremarketinsights.com/checkout/14232

Electrical Stimulation: Revolutionary Technique that Got Quadriplegic People Back on their Feet.

Electrical stimulators which were originally designed to treat chronic pain helped more than a dozen patients with quadriplegia to wiggle their toes, flex their legs or even walk with support.

This was a revolutionary technique which was conducted in the lab of University of Louisville in Kentucky. Electrical stimulation thus made promising and huge gains for people with paralysis wanting to regain their functionalities. The study was published in July 2019, after which thousands of patients have enrolled in the wait lists for the electrical stimulation technique.

U.S. and Canada Quadriplegia Treatment: Regional Outlook

U.S. and Canada region was found to be the largest market for the diagnosis and treatment of spinal cord injury (SCI). Increasing awareness and advanced technologies are the main drivers of this market. Most of the accidents found that alcohol was one of the most important factors; that is, approximately 25% of spinal cord injuries.

In the United States, the average annual medical cost for treating an acute spinal cord injury has been found to be in the range of $ 15,000 to $ 30,000 per year. All these factors are expected to drive the market growth of quadriplegia treatment market and offer lucrative opportunities for the providers.

Europe Quadriplegia Treatment: Regional Outlook

Europe was observed to be the second largest market, region wise for the quadriplegia treatment industry. Some of the factors contributing to this large market share are the presence of leading research institutes in the region for various neurological disease diagnosis and treatment. Increased awareness regarding various new technologies which help the quadriplegic patients lead a relatively normal life is also another key driver for this industry in Europe.

For critical insights, request for PDF Brochure@

https://www.futuremarketinsights.com/reports/brochure/rep-gb-14232

Who are the key player of Quadriplegia Treatment Market?

Major manufacturers of medications needed to treat quadriplegia are

• Merck & Co.
• Sanofi Pharmaceuticals
• Baxter International
• Zydus Cadila
• GlaxoSmithKline
• AstraZeneca
• Cipla
• Johnson & Johnson
• Bristol Myers Squibb Co.
• Eli Lily & Co.
• Teva Pharmaceuticals
• Takeda Pharmaceutical Co Ltd
• Hoffmann La Roche
• Sun Pharmaceuticals.

In November 2020, Pfizer and Mylan announced the merger of Pfizer’s Upjohn generics unit and Mylan. This deal was a part of restructuring drive at Pfizer, which was aimed for stronger foothold in the innovative medicines division of the company.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

 

According to the latest research by Future Market Insights, the Compounding Systems Market will undergo a steady growth during 2021-2031. Automated compound system is a container that is used in transferring medicines.

A gradual increase due to constant research studies being conducted and new verticals of disease treatment being opening can be seen over the mentioned forecast period. The growth is attributed because of the increase in the various techniques in chemotherapy.

What is driving Demand for Compounding Systems Market Forecast?

The demand for compounding systems market has seen at a higher rate at a global level as there has been increase in the number of chronic diseases growing at a different level. The rising ageing population and sedentary lifestyle owes for the demand for the market. Furthermore, the adoption in different mechanisms in chemotherapy treatment is high.

The urge in being efficient and accurate is yet driving the demand for the market growth.  The growing demand in personalized medications in treating malignant diseases i.e. high thus making the market grow steadily. Government organizations are highly involving themselves into alternatives to avoid medications errors, making the manufactures and researchers to boost themselves. Pharmacies are moving forward in the process of decentralization with the growing demand for compounding systems.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14034

Alternating therapeutics market is exploring themselves globally. The rise in malignant cases has lead the automated compound system to take a hike into hospital settings to avoid medication errors.  Hospitals are facing multiple medication errors which to avoid compounding systems works significantly in order to deliver proper treatment.

For example, National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) has been working on increasing awareness in the healthcare sector so as to prevent medication errors and ways to deliver safe treatment. As NCC MERP reports, approximately 0. 1 million people admitted in a hospital die because of the medication errors. Moreover, the death rate is not only in the hospital settings but in every way possible where people are undergoing treatments, hence to avoid minimal errors government is encouraging the compounding system for a better health.

U.S. Compounding Systems Market Outlook

U.S. is said to be the most dominating market due to its well-developed health infrastructure, in terms of disease treatment rate.  Hospital acquired infections is the major reason to boost the compounding systems market. The leading geriatric population in the US, the rising disease conditions like cancer demanding chemotherapy has made the compounding system to grow in the US.

According to a report by CDC, there were nearly 722,000 HAIs in the U.S. According to the US National Institute for Occupational Safety and Health (NIOSH), in the US 8 million healthcare workers are at risks as they’re more prone to hazardous drugs in a hospital settings. The WHO and International Agency for Research on Cancer (IARC)  forecasted that by 2025, every year, rise in cancer cases will number into 19 million . The United States accounts for the majority of the automated compounding devices (Oncology) market share in 2021.

Europe Demand Outlook for Compounding Systems Market

In 2019, the gravimetric automated compounding systems has occupied the largest market share in the Europe region. To avoid medication errors government has been indulging into the compounding market leading the market to grow. Advancement in technology is seen to grow in the given forecast period.

R&D are expanding themselves in developing new drug every now and then, leading in enormous demand in the market. European Commission estimates that some 20 million European healthcare workers are at similar risk. The growing cancer prevalence rate leading to increase in demand in chemotherapy may grow lead the market too boost in this region.

Who are the Key Manufacturers and Suppliers of Compounding Systems Market?

• Baxter International Inc.
• Braun Melsungen AG
• Comecer
• ICU MEDICAL INC.
• Grifols, S.A.
• OMNICELL INC.
• EQUASHIELD
• ARxIUM
• Weibond Technology
• NewIcon
• Arxium

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Compounding Systems Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

To gain more insights into the market with a detailed table of content and figures, click here:  https://www.futuremarketinsights.com/toc/rep-gb-14034

Key Segment

By Product Type:

• Gravimetric Automated Compounding Systems
• Volumetric Automated Compounding Systems

By End User:

• Hospitals
• Clinics
• Diagnostic Centres
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

 

According to the recent research by Future Market Insights, the endoscope tracking solutions market is set to witness a 9.0% growth during the forecast period from 2021 to 2031.

The growth will be experienced due to the rising endoscopic procedures in the world. Therefore, there will be significant growth seen in the endoscope tracking solutions market.

What is driving the Demand for Endoscope Tracking Solutions Market?

Endoscope tracking solutions is a reprocessing management tool that tracks and documents the workflow and status of the endoscope. Many factors are driving the demand for endoscope tracking solutions such as rising endoscopic procedures in the developed and developing countries, growing geriatric population and increasing emphasis on improving reprocessing guidelines by healthcare facilities.

The cases of infections caused due to the use of endoscopes have been considerably increasing which results in endoscope-associated infections. These infections can occur due to improper sterilization, are compelling healthcare workers to undertake several initiatives to reduce the risk of infections for patients. Thus, plays a vital role in driving the endoscopic tracking solutions market during the forecast period from 2021 to 2031.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14036

Rising Prevalence of Digestive System’s Cancer Likely to Propel the Growth of Endoscope Tracking Solutions Market

An endoscopy collects tissue samples (biopsy) for testing the diseases and conditions such as bleeding, inflammation or cancers of the digestive system.

According to PubMed, stomach cancer is the 3rd most deadly cancer in the world. According to GLOBOCAN 2020, 4.8 million new cases of gastrointestinal cancer was recorded in the world.

Therefore, the rising cases of cancer are expected to enhance its sales during the forecast period from 2021 to 2031.

U.S. and Canada Endoscope Tracking Solutions Market Outlook

The cases of stomach cancer are rising in the U.S. According to the American Cancer Society’s study, there will be approximately 26,560 new cases of stomach cancer in the U.S. in 2021. Also, the risk of cancer increases with the increasing older age population at any place.

Also, the advancement in technology plays an important role in increasing the sale and demand of endoscope tracking solutions worldwide.

Therefore, the demand for endoscope tracking solutions will increase during the forecast period from 2021 to 2031.

Europe Demand Outlook for Endoscope Tracking Solutions

Smoking is a major cause of cancer. Poisons that are found in cigarette smoke can weaken the immune system of the body, thus making it harder to kill cancer cells. According to WHO, 27% of cancer cases in Europe are due to tobacco use in 2018.  Thus, endoscope tracking solutions sales will also increase in the region during the forecast period from 2021 to 2031.

Who are the Key Manufacturers and Suppliers of Endoscope Tracking Solutions?

The key players of endoscope tracking solutions include

• Cantel Medical
• Olympus Corporation
• CONMED Corporation
• Micro-Scientific
• LLC
• Borer Chemie AG
• ARC Healthcare Solutions
• Custom Ultrasonics
• Richard Wolf GmbH and others.

The above companies follow certain strategies like merger & acquisition, getting FDA approval, and new product launches to be at the top position in the market. For instance, in July 2020, Olympus Corporation announced the agreement to acquire Arc Medical Design. This acquisition benefits the company by improving the early detection and treatment of colorectal cancer.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Integrated Endoscope Tracking Solutions Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14036

Key Segments

By Technology:

• RFID based
• VESA pattern
• Compatible hand-free data entry

By Indication:

• Gastroesophageal Reflux Disease
• Ulcers
• Stomach Cancer
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Clinics

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

 

According to the latest research by Future Market Insights, the Faecal Calprotectin Testing Market will witness growth during 2021-2031. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.

With increase in prevalence of inflammatory bowel syndromes and cancer, this market will receive boost due to scientists’ will to find new ways to treat diseases in the forecast period to the global market.

What is Driving Demand for Faecal Calprotectin Testing Market?

Crohn’s disease and ulcerative colitis come under the gambit of inflammatory bowel syndromes. Calprotectin is a serum which is present at site of any kind of inflammation; hence it is also called as an inflammatory marker or biomarker. Making IBS a major driver in this testing market. Changes in calprotectin levels of a faecal sample can play a major role in identifying the bowel syndromes which cause inflammation, making it a major driver of the market.

The capability of calprotectin to be able differentiate between irritable bowel syndrome and inflammatory bowel syndrome makes is a most impactful driver of this market. This uniqueness of calprotectin makes it swift in detection and treatment of bowel related diseases.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14039

Constant alteration in the diet of individuals raise the risk of IBS and increase an individual’s susceptibility towards it. A more detailed study to understand this relation will definitely assist in making necessary changes in its testing and act as a driving factor.

Prediction of post-operative recurrence of Crohn’s disease –

As published by researchers in the Digestive and Liver Disease Journal in May 2020, faecal calprotectin has a potential application in detecting the reoccurrence of Crohn’s disease.

As established earlier, Calprotectin presents itself at the site of any kind of inflammation and is therefore known as an inflammatory biomarker. This recent study shows that this serum can also act as predictive indicator in some cases. Variation in its levels in the patients with history of Crohn’s disease proved to be an indicator of recurrence of the disease. This and many future findings will help in making individuals actively do the testing and hence give a boost to the market.

U.S. and Canada Faecal Calprotectin Testing Market –

According to Centre for Disease Control, colorectal cancer ranks 4^th among the top 10 cancer prevalence in US. Investments and government support in conducting research in various verticals will definitely attract more attention to the faecal calprotectin market.

Developments like these showcases the encouragement provided by the authorities in developing novel systems. This will definitely aid U.S in dominating the market as there is an increase in importance of detection, prevention and treatment disease will further boost this market.

Europe Faecal Calprotectin Testing Market –

European region seems to be at the front for faecal calprotectin testing. Looking at the recent developments, European authorities tend to focus on encouraging exploration of new applications in any section of healthcare sector. A very peculiar study published in the Scandinavian Journal of Gastroenterology, explored the application of calprotectin faecal testing in diagnosis of colorectal cancer, as abdominal complaints are quite common in colorectal cancer patients.

Another interesting development which makes Europe a leading market in this market, is a study conducted with an attempt establish a connection between dermatological complications and faecal calprotectin. According to this Journal of Clinical and Experimental Dermatology published article, skin lesions are very common occurrence in inflammatory bowel syndrome (IBS). Given the sensitivity of the serum calprotectin towards inflammation, proper targeted testing done in this direction will definitely give a boost to this market.

Who are the key manufacturing and supplying companies in Faecal Calprotectin Testing Market?

Key Players:

• ALPCO
• Alpha Laboratories
• bioMérieux SA
• Canvax Biotech
• DRG Instruments GmbH
• Promega Corporation
• Svar Lifescience (CALPRO)
• Arbor Assays
• Werfen
• BUEHLMANN

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Faecal Calprotectin Testing Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14039

Key Segments –

By Assay Type:

• ELISA (Enzyme linked Immunosorbent Assay)
• Enzyme fluoroimmunoassay
• Quantitative immune-chromatography

By Application:

• Crohn’s Disease
• Ulcerative Colitis
• Colorectal Cancer

By End User:

• Hospitals
• Diagnostic Laboratories
• Ambulatory Care Centres
• Research Institutions

By Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, the Faecal Extraction System Market will witness growth during 2021-2031. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.

Being a disruptive system in itself, faecal extraction systems market is in need of  research investments to boost it in the given forecast period to global market.

What is Driving Demand for Faecal Extraction System Market?

Faecal extraction system is a type of device or a tool used to collect stool samples for the purpose of detecting presence of any kind of bacteria, virus, or any other type of parasitic foreign particle present in the stool. Positive identification of these parasites concretes presence of an infection in the body.

According to CDC, there was an increase in hospitalization rate from 44.2% to 59.7% between the years 2001 & 2018. This increase is attributed to increase in inflammatory bowel diseases in the United States as over 3 million individuals were affected from this disease. Also, interestingly all majority of these increase in cases was in individuals with Medicare beneficiaries. This shows the rising awareness among common man about getting tested for IBD  as its increase is becoming imminent cause of hospitalization.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14040

Stools samples can prove to be potentially important for diagnosing bowel infections, various syndromes which cause poor absorption of the nutrients. This system if executed effectively can help reduce the number of other diagnostic tests which can sometimes prove to be cumbersome and discomforting for the patient. Making it one of the major drivers of this market.

Diverse application of one single stools sample is yet another unique driver for this market. Analysis of a stool from different perspectives like microscopic, immunological, microbiological, chemical, etc. can be done to reach a differential diagnosis. Also, infections occurring from many different type of parasites like bacteria, viruses, etc. can leave their trace in the stool of an individual.

Faecal Extraction System in preventing incontinence-associated dermatitis (IAD) –

According to a study published in Australian Critical Care Journal in the year 2021, there is exists a relation between dermatitis caused due to incontinence and the system used to collect a stool sample, connected to continuous low-negative-pressure suction devices.

The researchers suggested that, anal pouch with ongoing low-negative-pressure suction can prove to be effective in collecting stools samples of people critically ill with faecal incontinence. Even though, further more in-depth studies are required, this study has never the less paved as path for future researchers to walk on. Wherein they can conduct deep research regarding these faecal collection systems with an aim to reduce the overall discomfort of pain as well as reduce the risk of post-colllection inflammations of the skin like dermatitis.

U.S. and Canada Faecal Extraction System Market –

With state-of-the-art healthcare as well as ceaseless research projects undertaken in U.S, will make them a dominant market in North American market. Recent development (2018) by a key market player Werfen, wherein, their proprietary faecal extraction device received a clearance by US FDA. ALPCO, which is another important player in the market received a US FDA 510(k) clearance for its Faecal Calprotectin ELISA.

Developments like these showcases the encouragement provided by the authorities in developing novel systems. This will definitely aid U.S in dominating the market as there is an increase in importance of detection, prevention and treatment disease will further boost this market.

Europe Faecal Extraction System Market –

The second dominant market in faecal extraction systems will be Europe. Focused research on new product development with the help of testing the product among the masses is actively on the rise in Europe. Buehlmann in collaboration with Telia Company (e-health platform developers) developed a tele-health system specific to inflammatory bowel diseases. In this application interface, comprehensive IBD patient monitoring, along with constant communication with the healthcare professionals and the patients on the condition of the patient, status of their faecal tests, etc. can be done.  Technological advancements like these are sure to bring in a new perspective into testing and report dispensing in this market.

Who are the key Manufacturing and Supplying Companies in Faecal Extraction System Market?

Key Players:

• ALPCO
• Alpha Laboratories
• bioMérieux SA
• Canvax Biotech
• DRG Instruments GmbH
• Promega Corporation
• Svar Lifescience (CALPRO)
• Arbor Assays
• Werfen
• BUEHLMANN

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Faecal Extraction System Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14040

By Assay Type:

• Calprotectin
• Albumin
• Haemoglobin
• Bile Acids
• Others

By Indication:

• Parasitic Infection
• Viral Infection
• Bacterial Indication
• Poor Nutrient Absorption

By Analysis Test:

• Microscopic
• Chemical
• Immunological
• Microbiological

By End User:

• Diagnostic Centres
• Hospitals and Clinics
• Ambulatory Clinics
• Research Centres

By Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, the Fish-Oil Based Drugs Market will witness growth during 2021-2031 with a CAGR of 8.4%. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.

With increase in prevalence of inflammatory bowel syndromes and cancer, this market will receive boost due to scientist’s willingness to find new ways to treat diseases in the forecast period to the global market.

What is Driving Demand for Fish-Oil Based Drugs Market?

Oils extracted from fish is rich in Omega-3 fatty acids known as Eicosapentaenoic Acid (EPA), Docosahexaenoic acid (DHA). It is also known to refrain the blood from clotting easily. These compounds help in reducing pain and inflammation caused to the human body, making these healing property of fish-oil a major driver in this market.

Furthermore, the mentioned healing properties result into its application into treatment and management of various diseases like coronary heart disease (CHD), Raynaud’s Syndrome, etc. This ability to help in treating diseases across diverse verticals of ailments is another important driver for this drug market.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14041

When any kind of inflammation occurs in the human body, some inflammatory bio-markers like calprotectin congregate at the site. Inflammation is a common occurrence in rheumatoid arthritis. Therefore, a June 2021 study published in the Nutrition Journal of Science Direct evaluated the effects of Fish Oil along with Cranberry juice in patients suffering from rheumatoid arthritis. This at the end proved to be beneficial for the patients as the inflammation as well as the inflammatory biomarkers were decreased after consuming this combinations.

Fish-oil in treatment of Neuro-degenerative Diseases –

An intriguing study was published in Springer (26 March 2020) which studied role of fish-oil along with butter-oil against Oxidative stress. These two oils were used in combination with an anti-Alzheimer drug known as galantamine hydrobromide.

Aim was to study was discover its role in improving brain permeation and providing neural protection against oxidative stress. The results showed the when co-administered, FO and BO enhanced the permeation level of the brain but also improved drug delivery across the blood brain barrier which can further help in treatment of any neurodegenerative diseases that cause oxidative stress.

U.S. and Canada Fish-Oil Based Drugs Market –

According to Centre for Disease Control, 1 person dies every 36 seconds due to some kind of cardiovascular condition in the US. Also, CDC projected that by 2025, 67 million Americans will get affected by arthritis in a year. Fish-oil plays an important treatment of these diseases.

Recently, at the end of 2019, FDA approved a drug which is based on fish-oil as a preventive medicine of heart attack and stroke. Icosapent ethyl is a purified form of EPA was officially approved by USFDA.

Developments like these will aid U.S in dominating the market as the increase in importance of detection, prevention and treatment of any disease will further boost this market.

Europe Fish-Oil Based Drugs Market –

European region is close to America in fish-oil based drugs market. Statistics given by European Brain Council say that 1 in 8 European is affected by some kind of neural system disease. Owing to the recent researches and to the facts mentioned above, fish-oil based drugs are sure to experience a good boost in Europe. Key European players include BASF SE, GC Rieber Oil, etc.

Who are the key manufacturing and supplying companies in Fish-Oil Based Drugs Market?

Key Players:

• Solutex GC
• Aker Biomarine
• Croda International PLC
• Stepan Company
• Pharma Marine
• GC Rieber Oil
• Clover Corporation
• BASF SE
• Cellana
• Omega Protein Corporation
• United Laboratories

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Fish-Oil Based Drugs Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14041

Key Segments –

By Source type:

• Mackerel
• Tuna
• Herring
• Salmon
• Others

By Form type:

• Eicosapentaenoic Acid (EPA)
• Docosahexaenoic acid (DHA)

By Indication:

• Coronary Heart Disease (CHD)
• Rheumatoid Arthritis
• Stroke
• Raynaud’s Syndrome
• Dysmenorrhea
• Other

By Distribution Channel:

• OTC
  • Supermarkets/ Hypermarkets/Food Stores
  • Drug Stores & Pharmacies
  • Online Retailers
  • Others
• Prescribed

By Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

According to the latest research by Future Market Insights, the glucagon injectable market is set to experience 5.4% growth during the year 2021-2031. Glucagon is a hormone that mobilizes the glucose in the blood circulation, through the breakdown of glycogen to glucose. Deficiency of this hormone causes a condition called hypoglycaemia.

To treat hypoglycaemia, glycogen injections and tablets are given to the patients. Glycogen injections are used for the treatment of severe hypoglycaemia and diagnostics purposes. In diagnostics, it is used for radiographic examination of the small bowel, duodenum, colon and stomach when diminished intestinal motility would be advantageous. The glucagon injectable market is mainly driven by an increase in the prevalence of type 1 and type 2 diabetes, new product launches and hypoglycaemia unawareness.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14042

What is the Driving Demand for Glucagon Injectable?

Glucagon injections are used to treat severe hypoglycaemia and for diagnostics purposes. The growth of this market is anticipated due to the rise in prevalence of diabetes, unawareness about hypoglycaemia and new product launches by the market players.

According to the International Diabetes Federation report, by 2045, globally there will be 700 million people between 20-79 years who will be suffering from diabetes. On average a person having type 1 diabetes suffers at least 2-3 episodes of hypoglycaemia in a week. This acts as a driver for the glucagon injectable markets. Sometimes people having blood sugar levels below 70 mg/dL and do not experience any symptoms.

This is called hypoglycaemia unawareness and these people are at a higher risk of any severe hypoglycaemia episode. According to a study conducted by the HAT Brazil study group 20.6% and 10.6% of people with type 1 and type 2 diabetes respectively showed asymptomatic hypoglycaemia. This acts as a driver for the market. The companies are investing in the research and development of glucagon injectable and for their approval. For instance, in December 2020, FDA approved the first generic glucagon injection for the treatment of hypoglycaemia and diagnostics aid.

Impact of COVID on Glucagon Injectable Market

The COVID-19 has impacted the glucagon injectable market. Due to the pandemic, the research and development were mainly carried out in the field of COVID. Due to this shift, the research of glucagon injectables was affected.

Also, with the change in lifestyle and eating habits, the prevalence of diabetes has increased. Therefore, putting people at a higher risk of diabetes and hypoglycaemia. Hence, COVID-19 had both positive and negative impacts on the glucagon injectable market.

Regional Demand Outlook for Glucagon Injectable

The glucagon injectable market is dominated by the North American region. This is due to the presence of the leading market player, the availability of glucagon injectable and the growing geriatric population. According to a UN report, the geriatric population will increase from 9.3 per cent in 2020 to around 16.0 per cent in 2050. Due to the combined effect of impaired pancreatic islet function and increasing insulin resistance with ageing, this population are at a higher risk of developing type 2 diabetes.

These factors drive the market in this region. Also, the expiration of patents of leading drugs is expected to surge the demand of the market. Followed by North America, Europe and Asia is dominating the glucagon injectable market. This is due to the presence of key market players in Europe and the increasing geriatric population.

For instance, as per Eurostat reported data in 2020, more than 20 % of the total population of Europe is above the age of 65. Moreover, awareness about the current treatments by the population plays a crucial role in the surge in demand for the glucagon injectable market during the forecast period.

Who are the Key Manufacturers and Suppliers of Glucagon Injectable?

The manufacturers and suppliers of glucagon injectables are

• Fresenius SE & Co. KGaA
• Xeris Pharmaceuticals Inc
• Novo Nordisk A/S
• ILS.Inc
• Amphastar Pharmaceuticals Inc.
• Lilly USA
• LLC. Zealand Pharma A/S.
• Avalon Pharma Pvt. Ltd

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Glucagon Injectable Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14042

Key Segment

By Application:

• Therapeutic purpose
• Diagnostics purpose

By Age group:

• Paediatrics
• Adults

By Route of administration:

• Subcutaneous
• Intramuscular
• Intravenous

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa

 

IV Disinfecting Caps Market is looking forward to grow at a higher rate in the forecast period of 2021-2031. It is estimated that nearly, 32.0% of HAIs are urinary tract infections (UTIs), 22.0% are surgical site infections (SSIs), 15.0% are pneumonia, and 14.0% are bloodstream infections (BSIs). IV caps are most useful in avoiding hospital acquired infections and helps hospital staff to protect themselves.

The IV disinfecting caps market is said to grow steadily as the increase in number of hospital admissions and infections that can be easily affected to the people in it. Society for Healthcare Epidemiology of America (SHEA) and other top infection-control organizations in 2014 recognized the use of disinfection caps for hospitals.

What is driving Demand for IV Disinfecting Caps Market?

The demand for IV Disinfecting Caps Market has seen at a higher rate at a global level as there has increase in the number of diseases that leads into surgery. Furthermore, the rising ageing population and lack of hygiene is expected to drive the market. According to a CDC report in 2018, around 1.7 million cases of HAIs and around 99,000 associated deaths are reported each year in American hospitals.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14055

Precautions and sanitation measures have been driving the market at a pace.  Globally, this diseases are more prone towards people with low immunity. The demand of IV Disinfecting Caps Market is on to the higher as Government is indulging into keeping the hospitals clean to avoid HAIs. Rise in cancer deaths every year has brought attention to parenteral nutrition, says WHO which leads to increase in demand for the IV Connectors. These reasons have said to be the driving factors for the market in the given forecast period 2021-2031.

U.S. IV Disinfecting Caps Market Outlook

U.S. is said to be the most dominating in terms of disease growth rate and will be the top one to boost the IV Disinfecting Caps Market. This is due to the rising number in the health diseases, and immunocompromised patients. According to CDC histoplasmosis is the commonest disease seen in HIV/ AIDS patients and due to their immunocompromised state 30% of them result in death.

This can be an opportunistic driving factor for the treatment market to grow. In addition, rising R&D and technological advancement in the region are some of the drivers of IV Disinfecting Caps Market. Ivera Medical Corporation, got approved with its Curos® disinfecting port protector, in January 2012, and it has been taking efforts in constantly improving its product. ICU Medical signed definitive agreement to acquire Pursuit Vascular, Inc. in January 2008.

Europe Demand Outlook for IV Disinfecting Caps Market

European Centre for Disease Prevention and Control (ECDC) in 2018, prevalence of HAIs in European countries was around 7.1%. It also reported that around 4,131,000 patients suffer from HAIs in Europe each year. The increasing focus on the healthcare facility, increase in the population of above 65 age group is likely to drive the market growth.

Furthermore, the growing chronic diseases which diminishes the immunity of a person and AIDS in the region are boosting the demand of IV Disinfecting Caps Market. Centre’s for Disease Control and Prevention (CDC), about 1 in 25 hospital patients has at least one healthcare-associated infection, on any given day. This has hiked the growth of the demand of disinfecting caps.

Who are the Key Manufacturers and Suppliers of IV Disinfecting Caps Market?

Some of the key players operating in the IV Disinfecting Caps Market are

• Phenomenome Discoveries Inc.
•  Human Metabolome Technologies, Inc.
• Thermo Fisher Scientific, Inc.,
•  Bio- Rad Laboratories, Inc.
•  Biocrates Life Sciences AG
• Agilent Technologies, Inc
•  Merit Medical
• BD
• 3M

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

IV Disinfecting Caps Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14055

Key Segment

By Product Type:

• Single Cap
• Double Cap

By End User:

• Hospitals
• Clinics
• Diagnostic Centre’s
• Others

By Application:

• Blood Collection,
• Blood Transfusion
• Infusion

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa